Cat. No. |
Product Name |
Information |
PC-72269 |
OP-5244
CD73 inhibitor
|
OP-5244 is a highly potent, orally bioavailable CD73 inhibitor with biochemical IC50 of 0.25 nM. |
PC-72241 |
CBLC000
FACT inhibitor
|
CBLC000 (CBL0100) is a small molecule histone chaperone FACT inhibitor, activates p53 and inhibits NF-κB with EC50 of 0.06 and 0.03 uM in cell-based p53 and NF-κB reporter assays, respecitvely. |
PC-72235 |
ENPP1 inhibitor QPS1
ENPP1 inhibitor
|
ENPP1 inhibitor QPS1 (QPS1) is a potent, selective non-competitive inhibitor of Ectonucleotide pyrophosphatase/PDE1 (NPP1, ENPP1) with Ki of 59.3 nM. |
PC-72215 |
BJP-06-005-3
Pin1 inhibitor
|
BJP-06-005-3 is a potent, selective, covalent, cell-permeable peptide Pin1 inhibitor (Ki=48 nM) that covalently target Cys113, a highly conserved cysteine located in the Pin1 active site. |
PC-72175 |
OXS007417
AML differentiation inducer
|
OXS007417 (OXS 007417) is a small moelcule that induces differentiation of AML cells in vitro (CD11b increasein HL-60 cell EC50=48 nM) and shows antitumor effects in vivo. |
PC-72156 |
I194496
CSE inhibitor
|
I194496 (I 194496) is a novel potent, selective inhibitor of cystathionine γ-lyase (CSE) inhibitor with IC50 of 0.79 uM. |
PC-72155 |
L-Propargylglycine
CSE inhibitor
|
L-Propargylglycine (L-PAG) is the most commonly used, covalently irreversible inhibitor inhibitor of cystathionine γ-lyase (CSE). |
PC-72154 |
CSE inhibitor 43
CSE inhibitor
|
CSE inhibitor 43 is a novel potent, selective, competitive inhibitor of cystathionine γ-lyase (CSE) inhibitor with IC50 of 1.2 uM. |
PC-72143 |
PCLX-001
N-myristoyl-transferase inhibitor
|
PCLX-001 (Zelenirstat) is a potent, selective, orally bioavailable N-myristoyl-transferases (NMT1/2) inhibitor with IC50 of 5/8 nM, respectively. |
PC-72138 |
NSC 773097
|
NSC 773097 is a RITA analog that produces hyperselective cytotoxicity while maintaining antitumor efficacy (A498 cell IC50=130 nM). |
PC-72132 |
BD50265
GPR52 agonist
|
BD50265 (BD 50265) is a potent small-molecule GPR52 agonist. |
PC-72130 |
WO-459
GPR52 agonist
|
WO-459 (WO459) is the first potent and orally available agonist of GPR52 with pEC50 of 7.53. |